New Delhi, May 5 (IANS) Claire Mazumdar, a US-based biotech entrepreneur and CEO of a Nasdaq-listed firm, on Tuesday identified as the future successor to Kiran Mazumdar-Shaw at Biocon, marking a key step in the company’s long-term leadership transition.Kiran Mazumdar-Shaw, founder and chairperson of Biocon, said she has formally charted a succession plan and chosen her niece Claire to eventually take over the reins of the company. She noted that as the sole owner of Biocon, it was important t…
Latest Kiran Mazumdar Shaw News & Updates
New Delhi, May 5 (IANS) Biocon founder Kiran Mazumdar-Shaw has named her niece Claire Mazumdar as her successor, outlining a formal succession plan for the biopharmaceutical company, according to a report.In an interview with Fortune India, Mazumdar-Shaw (73) said she sees Claire (37) as the right person to lead Biocon, a leading biopharmaceutical firm, into its next phase of growth.“I am the sole owner of Biocon, and I need to make sure that I put it in good hands. I have seen my niece Claire…
New Delhi, April 5 (IANS) Kiran Mazumdar-Shaw, Executive Chairperson of Biocon Limited, on Sunday raised concerns over the condition of NH44, the key IT corridor connecting the city to Hosur. In a social media post on platform X, she criticised the National Highways Authority of India (NHAI) for what she described as poor design and maintenance along the stretch.Mazumdar-Shaw highlighted that the medians and barricades along the highway are “terrible,” while the shoulders remain unpaved, cre…
New Delhi, Feb 1 (IANS) Industry experts on Sunday hailed the Union Budget 2026’s push to the biopharma sector, clinical trials, along with its thrust to the medical tourism and Ayurveda.The Union Budget 2026-27, presented by Finance Minister Nirmala Sitharaman in Parliament, proposed the Biopharma Shakti (Strategy for Healthcare Advancement through Knowledge, Technology, and Innovation) scheme.The scheme, with an outlay of Rs 10,000 crores over the next five years, aims to develop India as a …